Title: Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays
Xiaofang Bian
Special MTA: None
ATGGAATCCAGGATCTGGTGCCTGGTAGTCTGCGTTAACCTGTGTATCGTCTGTCTGGGT
GCTGTGGTTTCCTCTTCTTCTACTTCTCATGCAACTTCTTCTGCTCACAATGGAAGCCAT
ACTTCTCGTACGACGTCTGCTCAAACCCGGTCAGTTTCTTCTCAACACGTAACGTCTTCT
GAAGCCGTCAGTCATAGAGCCAACGAGACTATCTACAACACTACCCTCAAGTATGGAGAT
GTGGTGGGGGTCAACACCACCAAGTACCCCTATCGCGTGTGTTCCATGGCCCAGGGTACG
GATCTTATTCGTTTTGAACGTAATATCGTCTGCACCCCGATGAAGCCCATCAATGAAGAC
CTGGACGAGGGCATCATGGTGGTCTACAAACGCAACATCGTCGCGCACACCTTTAAGGTA
CGGGTCTACCAGAAGGTTTTGACGTTTCGTCGTAGCTACGCTTACATCCACACCACTTAT
CTGCTGGGCAGCAACACGGAATACGTGGCGCCTCCTATGTGGGAGATTCATCATATCAAC
AGGCACAGTCAGTGCTACAGTTCTTACAGCCGCGTTATAGCAGGCACGGTTTTCGTGGCG
TATCATAGGGACAGCTATGAAAACAAAACCATGCAATTAATGCTCGACGATTATTCCAAC
ACCCACAGCACCCGTTACGTGACGGTCAAGGATCAGTGGCACAGCCGCGGTAGCACCTGG
CTCTATCGTGAGACCTGTAATCTGAACTGTATGGTGACCATCACTACTGCGCGTTCCAAG
TATCCTTACCATTTTTTCGCCACGTCCACGGGTGACGTGGTTGACATTTCTCCTTTCTAC
AACGGAACCAATCGCAATACCAGCTACTTTGGAGAAAACGCCGACAAGTTTTTCATTTTC
CCGAACTACACTATTGTCTCTGACTTTGGAAGAGCGAATTCTGCGCCAGAGACCCACAGG
TTGGTGGCTTTTCTTGAACGTGCGGACTCGGTGATCTCCTGGGATATACAGGACGAGAAG
AATGTCACCTGTCAGCTCACCTTCTGGGAAGCCTCGGAACGTACTATTCGTTCCGAAGCC
GAAGACTCGTACCACTTTTCTTCTGCTAAAATGACTGCAACTTTTCTGTCTAAGAAACAA
GAAGTGAACATGTCCGACCCCGTGTTGGATTGTGTGCGTGATCAGGCTCTAAATAAGCTA
CAACAGATCTTCAACGCCTCGTACAATCAAACATACGAAAAGTACGGTAACGTGTCGGTT
TTTGAAACCACAGGCGGTCTGGTGGTGTTTTGGCAAGGTATCAAGCAAAAATCTTTGTTG
GAACTGGAACGTTTGGCCAATAGCTCCGGTGTGAACTCCACGCGTAGAACCAAGAGAAGT
ACGGGCAATACGACCACCCTGTCGCTTGAAAGCGAATCTGTACGAAATGTGCTCTACGCT
CAGCTGCAGTTCACCTATGATACGTTGCGCAGCTACATCAATCGGGCGTTGGCGCAGATC
GCCGAGGCCTGGTGTGTGGATCAACGGCGCACCCTAGAGGTCTTCAAGGAACTCAGCAAG
ATCAATCCATCAGCCATTCTCTCGGCCATCTACAACAAACCGATTGCCGCGCGTTTCATG
GGTGATGTTCTGGGTCTGGCCAGCTGCGTGACTATCAACCAAACAAGCGTCAAGGTGCTG
CGTGATATGAACGTGAAAGAATCGCCAGGACGCTGCTACTCACGACCCGTGGTCATCTTT
AATTTCGTCAACAGCTCGTACGTGCAGTACGGTCAACTGGGTGAGGACAACGAAATCCTG
TTGGGCAACCACCGCACTGAGGAATGTCAGTTTCCCAGCCTCAAGATCTTCATCGCCGGG
AACTCGGCCTATGAATATGTGGACTACCTCTTCAAACGCATGATTGACCTCAGCAGCATC
TCTACAGTCGACAGCATGATCGCCCTGGACATCGACCCGCTGGAAAACACTGACTTCAGG
GTACTGGAACTTTACTCGCAGAAAGAACTGCGTTCCAGCAACGTTTTTGACCTCGAGGAG
ATCATGCGCGAGTTCAACTCGTACAAGCAGCGGGTAAAGTACGTGGAGGACAAGGTAGTC
GACCCGCTGCCGCCCTACCTCAAGGGTCTGGACGACCTCATGAGCGGCCTGGGCGCTGCG
GGAAAGGCCGTTGGCGTAGCCATTGGGGCCGTGGGTGGCGCGGTGGCTTCCGTGGTCGAA
GGCGTTGCTACCTTCCTCAAAAACCCCTTCGGAGCCTTCACCATCATCCTCGTGGCCATA
GCCGTCGTCATTATCATTTATTTGATCTATACTCGACAGCGGCGTCTCTGCATGCAGCCG
CTGCAAAACCTCTTTCCCTATCTGGTGTCCGCCGACGGGACCACCGTGACGTCGGGCAAC
ACCAAAGACACGTCGTTACAGGCTCCGCCTTCCTACGAGGAAAGTGTTTATAATTCTGGT
CGCAAAGGACCGGGACCACCGTCGTCTGATGCATCCACGGCGGCTCCGCCTTACACCAAC
GAACAGGCTTACCAGATGCTTCTGGCCCTGGCCCGTCTGGACGCAGAGCAGCGAGCGCAG
CAGAACGGTACAGATTCTTTGGACGGACAGACTGGCACGCAGGACAAGGGACAGAAGCCC
AACCTGCTAGACCGACTGCGACATCGCAAAAACGGCTACCGACACTTGAAAGACTCTGAC
GAAGAAGAGAACGTC
MESRIWCLVVCVNLCIVCLGAVVSSSSTSHATSSAHNGSHTSRTTSAQTRSVSSQHVTSS EAVSHRANETIYNTTLKYGDVVGVNTTKYPYRVCSMAQGTDLIRFERNIVCTPMKPINED LDEGIMVVYKRNIVAHTFKVRVYQKVLTFRRSYAYIHTTYLLGSNTEYVAPPMWEIHHIN RHSQCYSSYSRVIAGTVFVAYHRDSYENKTMQLMLDDYSNTHSTRYVTVKDQWHSRGSTW LYRETCNLNCMVTITTARSKYPYHFFATSTGDVVDISPFYNGTNRNTSYFGENADKFFIF PNYTIVSDFGRANSAPETHRLVAFLERADSVISWDIQDEKNVTCQLTFWEASERTIRSEA EDSYHFSSAKMTATFLSKKQEVNMSDPVLDCVRDQALNKLQQIFNASYNQTYEKYGNVSV FETTGGLVVFWQGIKQKSLLELERLANSSGVNSTRRTKRSTGNTTTLSLESESVRNVLYA QLQFTYDTLRSYINRALAQIAEAWCVDQRRTLEVFKELSKINPSAILSAIYNKPIAARFM GDVLGLASCVTINQTSVKVLRDMNVKESPGRCYSRPVVIFNFVNSSYVQYGQLGEDNEIL LGNHRTEECQFPSLKIFIAGNSAYEYVDYLFKRMIDLSSISTVDSMIALDIDPLENTDFR VLELYSQKELRSSNVFDLEEIMREFNSYKQRVKYVEDKVVDPLPPYLKGLDDLMSGLGAA GKAVGVAIGAVGGAVASVVEGVATFLKNPFGAFTIILVAIAVVIIIYLIYTRQRRLCMQP LQNLFPYLVSADGTTVTSGNTKDTSLQAPPSYEESVYNSGRKGPGPPSSDASTAAPPYTN EQAYQMLLALARLDAEQRAQQNGTDSLDGQTGTQDKGQKPNLLDRLRHRKNGYRHLKDSD EEENV
Coding Sequence Details
Recommended Growth Condition: